Skip to content

Clinical trials

Phase 2/3 Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 2/3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20142
20181
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abcuro, Inc.1
AstraZeneca1
Auspex Pharmaceuticals, Inc.1
Centessa Pharmaceuticals (UK) Limited1
Lahey Clinic1
University of California, Davis1
University of California, San Diego1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases8
Central Nervous System Diseases4
Brain Diseases2
Mental Disorders2
Signs and Symptoms2
Alzheimer Disease1
Body Temperature Changes1
Bone Diseases1
Bone Resorption1
Brain Infarction1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.